Factory Price Pharmaceutical Chemical Fast Delivery Wholesale API CAS 857890-39-2 lenvatinib Mesylate CAS NO.857890-39-2
- FOB Price: USD: 0.02-0.03 /Gram Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: L/C,D/A,D/P,T/T,Other
- Available Specifications:
Top(1-1000)GramTop(1000-2000)Gram
- Product Details
Keywords
- CAS 857890-39-2
- lenvatinib Mesylate
- Lower Price lenvatinib Mesylate
Quick Details
- ProName: Factory Price Pharmaceutical Chemical ...
- CasNo: 857890-39-2
- Molecular Formula: C22H23ClN4O7S
- Appearance: White powder
- Application: Lenvatinib is a multi-targeted tyrosin...
- DeliveryTime: 3-7days
- PackAge: bag or barrel or drum
- Port: Shanghai or Shenzhen or Qingdao
- ProductionCapacity: 6000 Metric Ton/Day
- Purity: 99%+
- Storage: Store at room temperature
- Transportation: by express or air or sea
- LimitNum: 1 Gram
- Moisture Content: <0.001%
- Impurity: <0.001%
- Assay: 99%+
- Shelf Life: 2 years
- Appearance: White Powder
Superiority
English name: lenvatinib Mesylate
CAS number: 857890-39-2
Molecular formula: C22H23ClN4O7S
Molecular weight: 522.95862
EINECS Number: 812-398-0
Melting point:>220°C (dec.)
Storage conditions: -20°C Freezer
Solubility: DMSO (Slightly), Methanol (Slightly)
Form:Solid
Color: White to Off-White
Lenvatinib mesylate is the mesylate of lenvatinib, a multi-target tyrosine kinase inhibitor developed by Eisai, Japan, which has a novel binding mode, In addition to inhibiting other pro-angiogenic and oncogenic signaling pathway-related tyrosine kinases involved in tumor proliferation, it can selectively inhibit the kinase activity of vascular endothelial growth factor (VEGF) receptors, such as VEGF-1, VEGF-2, and VEGF- 3 and so on.
Lenvatinib is a multi-targeted tyrosine kinase inhibitor that may act on a variety of cancers, so Eisai is also conducting research on lenvatinib for other cancers, such as hepatocellular carcinoma, non-small cell carcinoma Cell lung cancer, melanoma, breast cancer, lymphoma, ovarian cancer, etc., through Yaodu data retrieval, there are 62 clinical research information related to lenvatinib. In July 2017, Eisai submitted a marketing application for lenvatinib to the US FDA and European Medicines Agency for the first-line treatment of advanced hepatocellular carcinoma. In clinical trials, lenvatinib was superior to the current standard of care drug sorafenib in patients with advanced hepatocellular carcinoma.
Q1.Are you a manufacturer or a trading company
A1.Our company is a leading manufacturer specializing in trade and the development, production and marketing of pharmaceutical intermediates and apis for more than 10 years.
Q2.What about the quality of your products
A2.We value quality as life.We strictly control the quality of each process, established a perfect quality control system.
Q3.In the third quarter.What is your minimum order quantity
A3.Our minimum order quantity is 1 gram.
Q4.Fourth quarter.Can you provide free test samples
A4.Yes, we can provide 10g free samples for consumer test.
Q5.What is your delivery time
A5.Delivery takes 2-3 days, depending on the destination.
Q6.What about the mode of transportation
A6.For urgent and light orders, UPS, FedEx, DHL, EMS can be used;For heavier goods, we provide the method of air or sea transportation to consumers.
Q7.So far.How about the terms of payment
A7.We accept T/T, Paypal, , money gram, etc.
Details
Wuhan Kanal Technology Co., Ltd. founded in 2010,it is a large manufacturer of fine Pharmaceutical& Chemical & Cosmetic materials that integrates R&D, production and sales together. Our Kanal company is established under the support of the Wuhan city government, so Kanal has large advantages in enterprise credit, finance security, product quality control, and cargo export.Kanal locates in the national new materials industry park of Wuhan city and is awarded the title of high-tech corporation.
Wuhan Kanal has its own R&D and development laboratory. We Kanal set up a R&D team with rich experience and strong technical strength, most of the practitioners have more than ten years' experience and technology in organic synthesis development. It owns almost 15 acre and more than 280 workers.
An ISO 9001 & GMP qualified company, we are mainly specialized in producing high quality but low price Pharmaceutical intermediates, APIs and other fine chemicals & cosmetics products which related to human and animals medicines as well as additives in gas &oil field, almost half of the goods are for exporting. What's more, we provide the OEM (customize) manufactures, if you can't find materials from the world, then tell us, we will research and produce in our high-tech equipmented laboratory. We are dedicated to satisfying our customers with our products and services.
1. We has 11 years' exporting experience in active pharmaceutical ingredient products.
Our professional and thoughtful after-sales service eliminates your worries.
2.We can provide you with ten thousands of products of different levels.
3. We offer convenient one-station purchasing service.
(1)Any inquiries will be replied within 12 hours.
(2)Dedication to quality, supply & service.
(3)Strictly on selecting raw materials.
(4)Reasonable & competitive price, fast lead time.
Our company is based on the optical valley biological city,making full use of the park policy advantages, focusing on the research and development of biological medicine.
The pharmaceutical intermediates are mainly applied to anti-cancer, anti-depression, cardiovascular, diabetes and other new medicine. The chemical intermediates mainly refer to heterocyclics and OLED intermediates.Our factory produce new fine chemical materials which are mainly used in water treatment, bactericidal and anti-corrosion, dyes, electronic materials and other industry fields.
Wuhan Kanal has export & import license, and hazard chemical sales license. The products are exported to America, Brazil, South Korea, Japan, Taiwan, Malaysia, Thailand, Indonesia, Europe union and other countries or regions.
Under rich experiences and excellent international reputation, the company becomes a quite influential enterprise in China's API field. Wuhan Kanal sincerely look forward to establishing long good cooperation with our customers from all over the world.